Examining the Effect of Metaverse-Based Epilepsy Education

NCT06195020 | Unknown

• 1 other identifier: 72867572-050.01.04
• Study Type: interventional
• Target: 70
• Locations: 1 country
• Sites: 1

Brief Summary

The research is a randomized controlled experimental study and was planned to examine the effect of metaverse-based epilepsy education on the epilepsy knowledge level of parents.

Conditions

Examining the Effect of Metaverse-based Epilepsy Education on Parents' Knowledge Level

Keywords

Epilepsy; metaverse; parent; knowledge level

Outcome Measures

Primary Outcomes (2)

• Introductory Form Regarding Parents and the Child's Illness

  This form consists of 9 questions and includes descriptive characteristics of the parents (age, mother/father, education level) and information about the epilepsy disease (mother/father age, educational status, occupation, diagnosis). questions (time, medications used, sources of information about the disease).

  3 months

• Epilepsy Knowledge Test Developed for Parents

  This test, developed by researchers in line with the literature, consists of 50 questions. Answers to each test question can be given as "true", "false" or "I don't know".

  3 months

Secondary Outcomes (2)

• Application Content and Quality Evaluation by the Expert Group [DISCERN Measurement Tool (Quality of Criteria for Consumer Health Information)]

  3 months

• System Usability Scale (SUS)

  3 months

Study Arms (2)

Experimental Group

EXPERIMENTAL

This group will be informed by sharing and using educational videos prepared in the Metaverse universe on mobile.

Other: Metaverse

Control Group

ACTIVE COMPARATOR

This group will be informed through routine outpatient clinic service.

Other: Polyclinic information

Interventions

Metaverse OTHER

The research consists of two stages (preparation and implementation). In the first stage of the research, the educational material planned to be used in the education of parents (video of navigation in the metaverse) will be developed in the form of modules. The topics in the training materials to be developed are listed below. Module 1: Information about Epilepsy (What is epilepsy?, What are the causes of epilepsy? Module 2 Diagnostic Methods in Epilepsy (Neurological examination, blood tests, electroencephalogram, screening tests 3rd Module Treatment of Epilepsy (Things to consider in patients receiving antiepileptic drug therapy) Module 4: First Aid in Epilepsy (first aid in seizures with convulsions, first aid in seizures without convulsions) Module 5: Life with Epilepsy (Epilepsy and school, epilepsy and career choice, epilepsy and home safety, epilepsy and exercise, epilepsy and healthy nutrition, epilepsy and sleep) The intervention will last 3 months.

Experimental Group

Polyclinic information OTHER

This group will be informed only at the outpatient clinic. The intervention will last 3 months.

Control Group

Eligibility Criteria

• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

• Must be able to use a smartphone with internet access
• Having a child diagnosed with epilepsy

You may not qualify if:

• Having an additional chronic disease (diabetes, chronic kidney failure, cancer, etc.) other than epilepsy

Sponsors & Collaborators

• Suleyman Demirel University: lead

Study Sites (1)

Mehmet Duray

Isparta, 32200, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Epilepsy

Condition Hierarchy (Ancestors)

Brain Diseases; Central Nervous System Diseases; Nervous System Diseases

Central Study Contacts

MEHMET DURAY

CONTACT

02462113268; mehmetduray@gmail.com

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: OUTCOMES ASSESSOR
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Assist Prof

Study Record Dates

• First Submitted: December 21, 2023
• First Posted: January 8, 2024
• Study Start: January 1, 2024
• Primary Completion: March 1, 2024
• Study Completion: June 1, 2024
• Last Updated: January 8, 2024

Record last verified: 2024-01

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)